Vivus (VVUS) is raising the bar on erectile dysfunction drugs, potentially becoming the latest formidable competitor to Viagra and Cialis in the $3.8 billion market. Investors in the California-based

Birds are singing, the sun is shining, and life is beautiful again. On the surface, the vital signs of our economy are improving with every economic report. In some areas, like unemployment, the rate

It's not easy to admit you're wrong. I don't typically keep up with "new technology." In fact, I've often been accused of living in the past. So, when I found out about Twitter --

For the tobacco industry, there’s a lot of money to be made by getting people hooked on cigarettes and keeping them as customers for life. But smoking cessation products are increasingly sendin

1. Two Economies, One Outcome: DeflationMost people mistake inflation and deflation as the simple idea that inflation means rising prices and deflation means falling prices. The problem is, those are

IEA Cuts Oil Outlook The International Energy Agency cut its long-term forecast for world oil demand due in part to lingering effects from the global recession, as well as new policies designed to cu

Editor's Note: This is Part 3 in a multiple-part series. Part 1 can be found here, Part 2 can be found here, and Part 4 can be found here. This series is the result of a question from Minyan Do

All day and every day, some of the stock market's best and brightest traders and money managers share their ideas, insights and analysis in real-time on Minyanville's Buzz & Ban

Perhaps the only real surprise from the Fed’s post-meeting statement yesterday, market pros note, is that there was no surprise at all.So says Dennis Gartman, editor of The Gartman Letter. As t

I’ve been in South America this week, speaking nine times in five days, interspersed with lots of meetings. The conversation kept coming back to the prospects for the dollar, but I was just as